|
SMARCD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6574519534629E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.07040004532411E-09 |
| Normal-vs-Stage2 |
7.121700E-03 |
| Normal-vs-Stage3 |
4.42510000000507E-05 |
| Normal-vs-Stage4 |
2.256600E-03 |
| Stage1-vs-Stage2 |
9.841400E-01 |
| Stage1-vs-Stage3 |
2.203400E-01 |
| Stage1-vs-Stage4 |
1.710180E-01 |
| Stage2-vs-Stage3 |
3.837800E-01 |
| Stage2-vs-Stage4 |
2.347200E-01 |
| Stage3-vs-Stage4 |
6.034000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.99504906723314E-12 |
| Normal-vs-AfricanAmerican |
6.8829000055004E-08 |
| Normal-vs-Asian |
2.601400E-01 |
| Caucasian-vs-AfricanAmerican |
3.581000E-01 |
| Caucasian-vs-Asian |
5.797600E-01 |
| AfricanAmerican-vs-Asian |
3.900600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.89335222447562E-12 |
| Normal-vs-Female |
2.9219999975183E-08 |
| Male-vs-Female |
5.569800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.04259999999623E-05 |
| Normal-vs-Extreme_Weight |
2.27359999999122E-05 |
| Normal-vs-Obese |
2.36600000036447E-07 |
| Normal-vs-Extreme_Obese |
6.056400E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.425600E-01 |
| Normal_Weight-vs-Obese |
4.678000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.622200E-01 |
| Extreme_Weight-vs-Obese |
2.022000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.700200E-01 |
| Obese-vs-Extreme_Obese |
7.196400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.00849999995489E-06 |
| Normal-vs-Age(41-60Yrs) |
1.67976743625786E-13 |
| Normal-vs-Age(61-80Yrs) |
3.40219999950264E-07 |
| Normal-vs-Age(81-100Yrs) |
1.606450E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.376760E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.057100E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.863810E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.323900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.927900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.760000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62503344114384E-12 |
| Normal-VS-Type2 PRCC |
1.300660E-03 |
| Normal-VS-KIRP CIMP |
3.595600E-02 |
| Normal-VS-Unclassified PRCC |
1.411330E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.373800E-04 |
| Type1 PRCC-VS-KIRP CIMP |
3.940800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.793000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.230600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.089800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.935000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.562230E-03 |
| Normal-vs-N1 |
2.20319999999496E-06 |
| Normal-vs-N2 |
1.749440E-01 |
| N0-vs-N1 |
1.130280E-02 |
| N0-vs-N2 |
2.689600E-01 |
| N1-vs-N2 |
9.362600E-01 |
|
|
